Children with metabolic syndrome at higher risk for diabetesOctober 15, 2015DiabetesLipid DisordersPediatricsObesity
EASD: Alirocumab lipid-lowering benefits extend to patients with high-risk diabetesOctober 1, 2015DiabetesLipid Disorders
Long-acting insulin degludec – and degludec combo drug – win FDA nodSeptember 26, 2015Lipid DisordersDiabetes
EASD: SGLT2 inhibitor empagliflozin cuts CV risk in patients with type 2 diabetesSeptember 18, 2015DiabetesLipid Disorders
Long-acting basal insulin controls HbA1c as well as glargineSeptember 16, 2015DiabetesLipid Disorders
Evolocumab is second PCSK9 inhibitor approved to lower LDL in high-risk patientsAugust 27, 2015Lipid Disorders
Mobile health technology may encourage behavioral changeAugust 13, 2015HypertensionLipid DisordersObesity
